Back to Search
Start Over
Modified Oral Rapid Drug Desensitization (ORDD) to Ibrutinib in a Patient with Stage IV Mantle Cell Lymphoma and Early Onset Grade 1 Hypersensitivity Reaction.
- Source :
- Journal of Allergy & Clinical Immunology; Feb2017 Supplement, Vol. 139, pAB38-AB38, 1p
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 00916749
- Volume :
- 139
- Database :
- Supplemental Index
- Journal :
- Journal of Allergy & Clinical Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 121130947
- Full Text :
- https://doi.org/10.1016/j.jaci.2016.12.180